These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5215559)

  • 41. [Current status of hormone therapy in metastasising breast cancer].
    Martz G
    Clin Ter; 1970 Jan; 52(2):107-13. PubMed ID: 5525590
    [No Abstract]   [Full Text] [Related]  

  • 42. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
    Hunter EM; Sutherland LA; Cree IA; Dewar JA; Preece PE; Wood RA; Linder D; Andreotti PE
    Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of hexoestrol in the therapy of advanced breast carcinoma].
    Monfardini S; Cunsolo A; Bonadonna G; Di Pietro S
    Minerva Med; 1970 May; 61(36):1968-74. PubMed ID: 5422054
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of 37 surgical cancers with associated or isolated chemotherapy].
    Montezin J
    Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093
    [No Abstract]   [Full Text] [Related]  

  • 45. The medical management of breast cancer.
    York RM
    J Med Assoc Ga; 1987 May; 76(5):342-4. PubMed ID: 3598407
    [No Abstract]   [Full Text] [Related]  

  • 46. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Israel L; Bernard E
    Poumon Coeur; 1968; 24(1):63-8. PubMed ID: 5690023
    [No Abstract]   [Full Text] [Related]  

  • 47. [Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
    Cavalli F; Beer M; Martz G; Jungi WF; Alberto P; Obrecht JP; Mermillod B; Brunner KW
    Schweiz Med Wochenschr; 1982 May; 112(22):774-83. PubMed ID: 7048518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trastuzumab: new indication. Metastatic breast cancer, in combination with docetaxel: promising, but more evaluation is needed.
    Prescrire Int; 2006 Feb; 15(81):3-5. PubMed ID: 16548094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevention and management of distant metastases in women with breast cancer.
    Glück S
    Cancer Invest; 2007 Feb; 25(1):6-13. PubMed ID: 17364551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer.
    Levine RM; Lippman ME
    Cancer Treat Rep; 1984 Apr; 68(4):573-6. PubMed ID: 6370427
    [No Abstract]   [Full Text] [Related]  

  • 52. Has first-line therapy had an impact on general outcome in metastatic breast cancer?
    McArthur HL; Hudis CA
    Future Oncol; 2007 Aug; 3(4):411-8. PubMed ID: 17661716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer-2. Chemotherapy and management of special problems.
    Rubens RD
    Nurs Times; 1975 Aug; 71(34):1334-6. PubMed ID: 1165996
    [No Abstract]   [Full Text] [Related]  

  • 55. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.
    Steinberg M
    Clin Ther; 2008 Sep; 30(9):1590-617. PubMed ID: 18840366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical trial of UFT against disseminated breast cancer].
    Itoh S; Konishi Y; Harauchi D; Shinoto M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2381-5. PubMed ID: 6437344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemotherapy of breast cancer. Standard treatment.
    Duffey PH
    Ariz Med; 1974 Mar; 31(3):197. PubMed ID: 4131961
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients.
    Einarsson R; Lindman H; Bergh J
    Anticancer Res; 2000; 20(6D):5089-93. PubMed ID: 11326674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
    Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
    Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.